Trinity Biotech plc

Equities

TRIB

US8964385046

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Other stock markets 09:53:35 2024-05-16 am EDT			5-day change	1st Jan Change
1.6 ^USD	+4.58%		-3.03%	-25.41%

May. 14	European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading	MT
May. 13	Trinity Biotech Secures Additional Orders For TrinScreen HIV Rapid Test Product	MT

Trinity Biotech plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023

October 03, 2023 at 09:15 am EDT

Trinity Biotech plc reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 13.9 million compared to USD 15.42 million a year ago. Net loss was USD 5.99 million compared to USD 9.71 million a year ago. Basic loss per share was USD 0.78 compared to USD 1.43 a year ago. Diluted loss per share was USD 0.78 compared to USD 1.43 a year ago.
For the six months, sales was USD 28.73 million compared to USD 31.09 million a year ago. Net loss was USD 11.8 million compared to USD 21.99 million a year ago. Basic loss per share was USD 1.546 compared to USD 3.756 a year ago. Diluted loss per share was USD 1.546 compared to USD 3.756 a year ago.

Latest news about Trinity Biotech plc

European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading	May. 14	MT
Trinity Biotech Secures Additional Orders For TrinScreen HIV Rapid Test Product	May. 13	MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	May. 10	MT
Trinity Biotech Announces the Appointment of Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development	May. 08	CI
Bank Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher Tuesday	May. 07	MT
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading	May. 06	MT
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower	May. 03	MT
European Equities Traded in the US as American Depositary Receipts Rise Modestly Higher in Thursday Trading	May. 02	MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	Apr. 25	MT
European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading	Apr. 23	MT
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading	Apr. 18	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	Apr. 17	MT
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading	Apr. 12	MT
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading	Apr. 11	MT
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower	Apr. 05	MT
Transcript : Trinity Biotech plc, Q4 2023 Earnings Call, Apr 04, 2024	Apr. 04
Trinity Biotech plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Apr. 04	CI
Trinity Biotech plc Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 04	CI
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading	Mar. 27	MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading	Mar. 26	MT
European Equities Traded in the US as American Depositary Receipts Ease Wednesday	Mar. 20	MT
European Equities Traded in the US as American Depositary Receipts Flat in Tuesday Trading	Mar. 19	MT
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading	Mar. 13	MT
European Equities Traded in the US as American Depositary Receipts Open Week Lower in Monday Trading	Mar. 11	MT
Trinity Biotech Says it Regained Compliance With Nasdaq's Minimum Bid Price Rule	Mar. 08	MT

Chart Trinity Biotech plc

Duration

Period

More charts

Company Profile

Trinity Biotech PLC is an Ireland-based develops, acquires, manufactures and markets medical diagnostic systems, including both reagents and instrumentation for the clinical laboratory and point-of-care segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Its segments include the Americas and Rest of World. It is a provider of raw materials to the life sciences and research industries globally. It also operates a licensed reference laboratory that specializes in diagnostics for autoimmune diseases. Its POC brands include Uni-Gold, Recombigen, MarDx, FlexTrans, Premier and Ultra. Its clinical laboratory brands include ImmuBlot, ImmuGlo, ImmuLisa, OTOblot and EZ. The Company manufactures kits for the detection of specialty and esoteric biomarkers of infectious diseases and other associated laboratory products.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-19 - Q2 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
TRINITY BIOTECH PLC	-25.41%	14.48M
BIOMÉRIEUX	-4.32%	12.32B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-4.76%	8.1B
DIASORIN S.P.A.	+9.02%	5.87B
LANTHEUS HOLDINGS, INC.	+29.23%	5.52B
AUTOBIO DIAGNOSTICS CO., LTD.	-6.28%	4.29B
10X GENOMICS, INC.	-54.19%	3.16B
ANDON HEALTH CO., LTD.	+12.93%	2.72B
VITROLIFE AB	-1.90%	2.37B
MYRIAD GENETICS, INC.	+26.37%	2.23B

Diagnostic & Testing Substances